B. Riley Financial Inc., seeking to recover from soured investments and a string of losses, has briefed its staff on a ...

The markets were closed on Monday for Martin Luther King Jr. Day, which also marked the inauguration of Donald J. Trump, the ...

B. Riley raised the firm’s price target on Verastem (VSTM) to $9 from $7 and keeps a Buy rating on the shares after speaking with management. The ...

B. Riley boosted their FY2024 earnings per share (EPS) estimates for Expedia Group in a report released on Tuesday, January 28th. B. Riley analyst N. Khan now forecasts that the online travel company ...

Stock analysts at B. Riley cut their FY2024 EPS estimates for Pangaea Logistics Solutions in a report released on Tuesday, January 28th. B. Riley analyst L. Burke now anticipates that the shipping ...

Learn about the latest financial trends and strategies in our comprehensive article written by a financial expert.

In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), ...

B. Riley analyst Kyle Bauser raised the firm’s price target on ClearPoint Neuro (CLPT) to $20 from $15 and keeps a Buy rating ...

The deferral affects B. Riley’s 6.875% Series A and 7.375% Series B preferred stock, according to a statement Monday. Dividends on those preferreds cost the company $2 million in the second ...

B. Riley Financial Inc. suspended dividends on a pair of its preferred shares, holding off on cash payments to some investors ...